Рак лёгких

Рак легких: новый метод скрининга апробируют в Казахстане в 2027 году

Рак легких: новый метод скрининга апробируют в Казахстане в 2027 году Новости Zakon.kz

'Immune fog' may flag lung cancer risk years before tumor develops

A 'rising fog' may cloud the immune system's ability to detect tumors and may be the key to tackling lung cancer that is developing years before diagnosis. The team at University College London (UCL) followed this signal using prototype blood tests and reversed it using drugs.

ALCMI and Sophos IRB Form Strategic Partnership to Advance Lung Cancer Clinical Research

ALCMI and Sophos IRB Form Strategic Partnership to Advance Lung Cancer Clinical Research Yahoo Finance

Lung Cancer Canada Breathe Forward Award: $200,000 for NSCLC Diagnostic Innovation

Lung Cancer Canada Breathe Forward Award: $200,000 for NSCLC Diagnostic Innovation Oncodaily

Рак лёгких можно будет остановить до появления опухоли? Учёные сделали открытие

Рак лёгких можно будет остановить до появления опухоли? Учёные сделали открытие Газета Балаково

Exercise During Chemotherapy: New Evidence Map Sets Safety Rules for Lung Cancer Patients

Exercise During Chemotherapy: New Evidence Map Sets Safety Rules for Lung Cancer Patients Bioengineer.org

Lung Cancer Drug Misses Trial Goal, but Shows Fewer Side Effects

Lung Cancer Drug Misses Trial Goal, but Shows Fewer Side Effects Cure Today

Personalized Vaccines May Have Utility Across All Lung Cancer Stages

150 people have received an experimental lung cancer drug in trials involving immunotherapy

150 people have received an experimental lung cancer drug in trials involving immunotherapy Stock Titan

MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer

MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer Yahoo Finance Australia

EGFR Non Small Cell Lung Cancer Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Astrazeneca, Bridge Biotherapeutics, Sichuan Kelun Pharma

EGFR Non Small Cell Lung Cancer Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Astrazeneca, Bridge Biotherapeutics, Sichuan Kelun Pharma StreetInsider

BioMILD at Nearly 10 Years: Risk-Adapted LDCT Screening Sustains Early Lung Cancer Detection With Extended Intervals

BioMILD at Nearly 10 Years: Risk-Adapted LDCT Screening Sustains Early Lung Cancer Detection With Extended Intervals Oncodaily

Taking The First Steps for a Personalized Lung Cancer Vaccine Trial

AVBP Stock Crashes More Than 48% To All-Time Low After Lung Cancer Trial Setback – Retail Calls It ‘Way Undervalued’

AVBP Stock Crashes More Than 48% To All-Time Low After Lung Cancer Trial Setback – Retail Calls It ‘Way Undervalued’ TradingView

Clinical trial for small cell lung cancer: Patricia's story

Clinical trial for small cell lung cancer: Patricia's story Roswell Park Comprehensive Cancer Center